AAAAAA
Results:
1-16
|
Results: 16
Authors:
BRISKI KP
Citation: Kp. Briski, GLUCOPRIVIC INDUCTION OF FOS IMMUNOREACTIVITY IN HYPOTHALAMIC DOPAMINERGIC-NEURONS, NeuroReport, 9(2), 1998, pp. 289-295
Authors:
BRISKI KP
SYLVESTER PW
Citation: Kp. Briski et Pw. Sylvester, ROLE OF ENDOGENOUS OPIATES IN GLUCOPRIVIC INHIBITION OF THE LUTEINIZING-HORMONE SURGE AND FOS EXPRESSION BY PREOPTIC GONADOTROPIN-RELEASING-HORMONE NEURONS IN OVARIECTOMIZED STEROID-PRIMED FEMALE RATS, Journal of neuroendocrinology, 10(10), 1998, pp. 769-776
Authors:
MCINTYRE BS
BRISKI KP
HOSICK HL
SYLVESTER PW
Citation: Bs. Mcintyre et al., EFFECTS OF PROTEIN-TYROSINE-PHOSPHATASE INHIBITORS ON EGF-DEPENDENT AND INSULIN-DEPENDENT MAMMARY EPITHELIAL-CELL GROWTH, Proceedings of the Society for Experimental Biology and Medicine, 217(2), 1998, pp. 180-187
Authors:
GILLEN E
BRISKI KP
Citation: E. Gillen et Kp. Briski, EXPRESSION OF FOS-LIKE PROTEINS IN THE PREOPTIC AREA AND HYPOTHALAMUSOF THE RAT-BRAIN FOLLOWING INTRACEREBRAL OR PERIPHERAL ADMINISTRATIONOF COLCHICINE, Neurochemical research, 22(5), 1997, pp. 549-554
Authors:
BRISKI KP
Citation: Kp. Briski, CENTRAL OPIOID RECEPTORS MEDIATE GLUCOPRIVIC INHIBITION OF PITUITARY LH-SECRETION, American journal of physiology: endocrinology and metabolism, 35(4), 1997, pp. 517-522
Authors:
BRISKI KP
DIPASQUALE BM
GILLEN E
Citation: Kp. Briski et al., INDUCTION OF IMMEDIATE-EARLY GENE-EXPRESSION IN PREOPTIC AND HYPOTHALAMIC NEURONS BY THE GLUCOCORTICOID RECEPTOR AGONIST, DEXAMETHASONE, Brain research, 768(1-2), 1997, pp. 185-196
Authors:
BRISKI KP
Citation: Kp. Briski, STIMULATORY VS INHIBITORY EFFECTS OF ACUTE STRESS ON PLASMA-LH - DIFFERENTIAL-EFFECTS OF PRETREATMENT WITH DEXAMETHASONE OR THE STEROID-RECEPTOR ANTAGONIST, RU-486, Pharmacology, biochemistry and behavior, 55(1), 1996, pp. 19-26
Authors:
BIRKENFELD HP
MCINTYRE BS
BRISKI KP
SYLVESTER PW
Citation: Hp. Birkenfeld et al., PROTEIN-KINASE-C ISOENZYME EXPRESSION IN NORMAL MOUSE MAMMARY EPITHELIAL-CELLS GROWN IN PRIMARY CULTURE, Proceedings of the Society for Experimental Biology and Medicine, 213(1), 1996, pp. 65-70
Authors:
BRISKI KP
SWANSON GN
SYLVESTER PW
Citation: Kp. Briski et al., SIZE AND CHARGE HETEROGENEITY OF PITUITARY AND PLASMA PROLACTIN IN THE MALE-RAT, Neuroendocrinology, 63(5), 1996, pp. 437-445
Authors:
BIRKENFELD HP
MCINTYRE BS
BRISKI KP
SYLVESTER PW
Citation: Hp. Birkenfeld et al., ROLE OF PROTEIN-KINASE-C IN MODULATING EPIDERMAL GROWTH FACTOR-INDUCED AND PHORBOL ESTER-INDUCED MAMMARY EPITHELIAL-CELL GROWTH IN-VITRO, Experimental cell research, 223(1), 1996, pp. 183-191
Authors:
BRISKI KP
VOGEL KL
Citation: Kp. Briski et Kl. Vogel, ROLE OF ENDOGENOUS OPIOID-PEPTIDES IN CENTRAL GLUCOCORTICOID RECEPTOR(GR)-INDUCED DECREASES IN CIRCULATING LH IN THE MALE-RAT, Neuropeptides, 28(3), 1995, pp. 175-181
Authors:
BRISKI KP
VOGEL KL
MCINTYRE AR
Citation: Kp. Briski et al., THE ANTIGLUCOCORTICOID, RU486, ATTENUATES STRESS-INDUCED DECREASES INPLASMA-LUTEINIZING HORMONE CONCENTRATIONS IN MALE-RATS, Neuroendocrinology, 61(6), 1995, pp. 638-645
Authors:
BRISKI KP
Citation: Kp. Briski, EFFECTS OF PERIPHERAL VERSUS CENTRAL ADMINISTRATION OF THE ENDOGENOUSGLUCOCORTICOID, CORTICOSTERONE, AND THE GLUCOCORTICOID RECEPTOR AGONIST, RU-28362, ON LH-RELEASE IN MALE-RATS, Brain research, 670(1), 1995, pp. 66-74
Authors:
BRISKI KP
SYLVESTER PW
Citation: Kp. Briski et Pw. Sylvester, ANTAGONISM OF TYPE-II, BUT NOT TYPE-I GLUCOCORTICOID RECEPTORS RESULTS IN ELEVATED BASAL LUTEINIZING-HORMONE RELEASE IN MALE-RATS, Neuroendocrinology, 60(6), 1994, pp. 601-608
Authors:
SYLVESTER PW
BIRKENFELD HP
HOSICK HL
BRISKI KP
Citation: Pw. Sylvester et al., FATTY-ACID MODULATION OF EPIDERMAL GROWTH FACTOR-INDUCED MOUSE MAMMARY EPITHELIAL-CELL PROLIFERATION IN-VITRO, Experimental cell research, 214(1), 1994, pp. 145-153
Authors:
SYLVESTER PW
IP MM
BRISKI KP
Citation: Pw. Sylvester et al., EFFECTS OF SPECIFIC FATTY-ACIDS ON PROLACTIN-INDUCED NB2 LYMPHOMA CELL-PROLIFERATION, Life sciences, 52(24), 1993, pp. 1977-1984
Risultati:
1-16
|